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Purpose: Cryopreserved arterial allografts may be used for arterial reconstructive proce- 
dures. In this experimental study cryopreserved arteries were used as autografts and as 
allografts with or without immunosuppression with cyclosporine A.
Methods: In group A (three dogs, six bilateral grafts) cryopreserved carotid artery autografts 
were implanted. In groups B and C female mongrel dogs (three dogs and six bilateral grafts 
in each group) received cryopreserved male carotid artery allografts. Dogs in group C were 
treated with cyclosporine A (25 mg/kg/day). After 3 months of implantation patency was 
assessed by angiography. Contractile responses to KCI and phenylephrine (Phe) and the 
endothelium-dependent r laxation response to methachollne (Met) were examined in 
segments of the grafts after excision. Medial thickness was assessed semiquantitatively. The 
grafts were stained for sex chromatin analysis to determine the origin of cells in allografts. 
Results: Patency: group A, 100% (6 of 6), group B, 66.6% (4 of 6), and group C, 100% (6 
of 6). Functional responses: before implantation, after thawing, 2.7 + 0.5 mN (KCI), 
4.8 + 1.0 mN (Phe), and 0.0% + 0.0% (Met), group A, 36.9 + 10.6 mN (KCI), 31.5 + 14.4 
mN (Phe), and 59.3% + 20.4% (Met), group B, 0 for all agents used, group C, 34.0 + 7.5 
mN (KC1), 28.8 + 7.0 mN (Phe), and 46.2% + 3.2% (Met). Morphologic haracteristics: 
the media of grafts in group B showed significant thinning (p < 0.05). Smooth-muscle c lls 
in vessel walls of grafts in group C were of female origin. 
Conclusion: Arteries howed no function and loss of endothelial integrity after cryopreser- 
vation and thawing. After 3 months of implantation cryopreserved arterial autografts and 
allografts under immunosuppressive treatment with cyclosporine A showed 100% patency 
and return of functional responses resulting from repopulation of grafts by host cells. 
(J Vasc Surg 1996;24:876-82.) 
Autologous veins are the grafts of choice for 
reconstruction f  both coronary and peripheral rter- 
ies. These veins are often unavailable, which leaves the 
cardiac or vascular surgeon in need of an alternative. 
Results with synthetic materials for limb salvage 
procedures have been disappointing. 1,2 This problem 
has stimulated research into the feasibility of using 
allogeneic veins as alternative conduits. 3-9 Unfortu- 
nately, late patency rates of allogeneic veins and 
allogeneic arteries were low as a result of antigenicity 
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of the grafts and subsequent deterioration caused by 
immunologic rejection. In addition, preservation of 
structural integrity of the graft over a period long 
enough to bridge the time from harvest to implanta- 
tion was an important obstacle in using allogeneic 
blood vessels. For these reasons the concept of using 
arterial allografts for vascular econstruction is only 
practicable when a method is found that allows 
long-term preservation and when the problem of 
immunologic rejection of vascular allografts i  solved. 
In previous experimental work we have evaluated 
the applicability of viable preserved arteries. 1° The aim 
of this study was to investigate whether cryoprcscr- 
vation is an appropriate method to preserve and store 
arteries. Cryopreservation has the advantage of long- 
term storage of arteries, but the consequences of 
cryopreservation with regard to acceptance and per- 
formance of these arteries when used for arterial 
grafting, is unclear. Cryopreserved arteries were 
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therefore implanted as autografts and as allografts in 
dogs with or without immunosuppression with cy- 
closporin A (CsA). Morphologic haracteristics and 
function of the arteries were assessed after 3 months of 
implantation. In addition, sex chromatin analysis was 
performed to determine the origin of cells residing in 
the allografts. 
MATERIAL AND METHODS 
Experimental groups. In this study three experi- 
mental groups were formed as shown in Table I. To 
determine the origin of cells after the implantation 
period, male dogs served as graft donors, and female 
dogs were used as graft recipients. Group A: three 
female dogs received two of their own cryopreserved 
arteries each as autografts. Group B: three female 
recipient dogs each received two cryopreserved arte- 
rial allografts from male donors. Group C: three 
female recipient dogs received six cryopreserved ar- 
terial allografts from male donors and were given CsA 
(25 mg/kg/day) after surgery. 
Cryopreservation. Carotid arteries were ob- 
tained from male mongrel dogs (25 + 3 kg) within 1 
hour after circulatory arrest. 11 For autograft studies 
carotid arteries were obtained from female mongrel 
dogs (25 + 3 kg). A temporary autologous jugular 
vein graft was inserted into the defect. Immediately 
after excision was performed, the arteries were stored 
in sterile containers with University of Wisconsin 
organ preservation solution (Viaspan, Du Pont Phar- 
maceuticals, Wilmington, Del.) at 4 ° C? ° The arteries 
were then transported in isothermic boxes to our 
cryopreservation facility. Cryopreservation was car- 
ried out with the same protocol as used for human 
cardiac valves.~2,~3 The arteries were placed in culture 
medium TC 199 (Tissue culture medium 199, Bio- 
whittaker, Walkersville, Md.) containing a range of 
broad-spectrum antibiotics (in ~tg/L: 12 amikacine, 
12 vancomycine, 12 metronidazol, 3 ciprofloxacine, 
30 flucitosine). After 24 hours dimethylsulfoxide was 
added as a cryoprotectant i  increasing amounts to a 
final concentration of 10%. The arteries were then 
placed in sterile bags and cryopreserved in a Kryo 10 
apparatus (Planer Biomed, Middlesex, U.K.) at a 
controlled cooling rate of-1 ° C/min up to -100 ° C. 
Subsequently the arterial grafts were stored in liquid 
nitrogen vapor (-197 ° C). Rapid thawing was carried 
out by submersion of the grafts in a 40 ° C water bath. 
To minimize toxic effects of dimethyl sulfoxide the 
cryoprotectant was removed by progressive dilution 
in TC 199 medium. 
Preimplantation i vitro evaluation. To exam- 
ine the effects of cryopreservation per se, six arterial 
Table I. Summary of experimental groups 
No. of grafts 
evaluated 
Graft Patency Functional Morphologic 
Groups type (%) analysis analysis 
A (n= 6) Autograft 6/6 (100) 6 6 
B (n = 6) Allograft 4 /6  (67) 4 6 
C (n = 6) Allograft + 6 /6  (100) 6 6 
CsA a 
Animals in group 3 were given 25 mg/kg/day: cyclosporin A. 
grafts cryopreserved for a 30-day period were evalu- 
ated functionally and morphologically immediately 
after thawing. 
Animal model. Cryopreserved carotid arteries 
were orthotopically transplanted into female mongrel 
dogs (n=9)  (25 + 1 kg). The animals received 
premedication with 5 mg/kg ketamine (Ketalar), 
2 mg/kg xylazine (Rompun), and 0.5 mg atropine. 
Subsequently they underwent intubation, and anes- 
thesia was performed with inhalation of a mixture of 
NO2/O 2 (1:1) and halothane (Fluothane) 1% to 
1.5%). With a median incision in the neck the right 
and left carotid arteries were exposed by splitting the 
sternocleidomastoid and long neck muscles, where- 
after the artery was cross-clamped. For initial au- 
tograft and allograft studies (group A and B) 2.5 cm 
arterial segments were used as grafts for practical 
reasons. In subsequent allograft studies under immu- 
nosuppressive protection with CsA, 6 cm segments 
were used to assess whether in longer grafts host 
lateral ingrowth could be demonstrated spanning the 
entire length of the graft. 
Autografts. In the autograft experiments, a 2.5 
cm segment was taken from the carotid artery and 
processed for cryopreservation. A segment of jugular 
vein underwent anastomosis in the defect. At reop- 
eration the cryopreserved autograft was orthotopi- 
cally implanted after the vein graft was excised with a 
cuff of normal artery. 
Allografts. Arterial allografts of male donors were 
orthotopically implanted into the carotid artery of 
host female dogs after an equal segment was excised 
from the carotid artery. All implants underwent 
anastomosis in an end-to-end fashion with a running 
7-0 Prolene suture (Ethicon Inc., Sommerville, NY). 
After completion, suction drains were positioned 
adjacent to the graft. After surgery long-acting 150 
mg/10 kg amoxicillin (Clamoxyl) was administered 
three times during 1 week. Postoperative pain was 
managed by 0.01 to 0.02 mg/kg buprenorphine 
(Temgesic) for 2 days. No anticoagulant agents were 
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Fig. 1. Analysis of graft function. Bar graph showing in vitro function after excision of grafts per 
group. Function of cryopreserved grafts after thawing, before implantation, is depicted for 
comparison. Contractile function is expressed as means + SEM of absolute force of contraction. 
Relaxation is expressed as percentage decrease from preconstricted level. After 3 months of 
implantation functional responses were restored in autografts and in allografts under CsA 
treatment, 25 mg/kg/day. A, Autografts; B, allografts; C, allografts +CsA 25 mg/kg/day. 
given before, during, or after surgery. In group C CsA 
(Sandoz) was administered orally starting the first 
postoperative day in daily doses of 25 mg/kg body 
weight. Blood samples were obtained weeldy to assess 
CsA serum levels. 
Angiography. After an observation period of 88 
days (+6 days) angiography ofthe carotid arteries was 
performed (Seldinger technique, 30 ml contrast me- 
dium [1:1 H20 ] [Radiopaque]). Subsequently the 
grafts were excised and prepared for functional, mor- 
phologic, and histologic evaluation. 
Assessment of  isometric stimulated contrac- 
tions and endothelium-dependent r laxation. Im- 
mediately after excision was performed, a ring (4-mm 
segment) was cut from the mid-portion of the graft 
for assessment of function of the vessel wall. The rings 
were mounted vertically between stainless steel hooks 
in organ baths (5 ml) for isometric recording of 
contraction and relaxation. 14The initial resting ten- 
sion was set at 20 mN and was continued throughout 
the experiment. The upper hook was connected to a 
force transducer (Kyowa, Tokyo, lapan). The signal 
was amplified (Kyowa) and recorded on a thermal pen 
recorder (WN, K, Kaltbrunn, Germany). The organ 
bath medium was maintained at 37 ° C, and pH was 
kept at pH 7.4 by bubbling the solution with carbo- 
gen O2/CO ~ (95:5). The tissue chambers contained 
Tyrode's solution of the following composition (in 
millimoles): NaC1 124, KC1 4.0, CaC12 0.9, MgC1 z 
1.I, NaH2PO 4 0.42, NaHCO 3 24.9, glucose 5.5. 
Contractile responses to 40 mmol /L  KCI (K +) 
and 100 gmol L-phenylephrine (Phe), and the endo- 
thelium-dependent relaxation response to 100 gmol 
methacholine (Met) were examined. The contrac- 
tions were expressed as absolute force of contraction 
in milliNewtons. Endothelium-dependent r laxation 
is expressed as the percentage decrease in tension 
from the preconstricted level, also presented as mean 
values + SEM. 
Determination of  baseline values. Baseline val- 
ues of the responses to 40 mmol /L  KCI, 100 gmol 
Phe, and 100 gmol Met were established as the mean 
of a group of freshly harvested carotid arteries 
(n : 10). 
Morphologic evaluation. The grafts were ex- 
cised with a cuff of native artery. After opening, lon- 
gitudinally, one half was placed in 10% buffered form- 
aldehyde for evaluation by light microscopy. The 
implants were divided into proximal, middle, and dis- 
tal thirds and were subsequently embedded in paraf- 
fin. Of these thirds, 5 gm sections were cut and stained 
with hematoxylin-cosin a d Giemsa's elastine stain. 
To dctermine the origin of the cells in the trans- 
planted grafts of group C, sex chromatin analysis was 
performed with orceine and quinacrine staining. 
When viable donor cclls are present in the grafts, they 
are of male origin and are expected to stain positively 
for quinacrine, showing typical Y-chromosome-re- 
lated bright fluorescent spots. When the graft has 
become repopulated with host cells, thc cells will be of 
female origin, and Barr bodies, specifically stained 
with orceine, can be expected in the specimens. 
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Fig. 2. Thickness of media. Bar graphs displaying thickness of media per dose regimen group 
compared with control group of arteries (n = 10). Mean values (+SEM) of proximal, middle, and 
distal thirds of grafts are shown. Grafts in group B show diminution of medial thickness, tt, 
Autografts; B, allografts; C, allografts +CsA 25 mg/kg/day. *p < 0.05. 
The thickness of the media was measured with a 
Leica, Quantimet 500 (Leica Cambridge Ltd., Cam- 
bridge, U.K.). The proximal, medial, and distal thirds 
were measured in up to five locations. Data were 
compared with a group of control arteries (n = 10) 
and presented as means _+ SEM. 
The specimens of proximal, middle, and distal 
graft thirds were scored for endothelial cell quality 
(EC) (as determined by the presence of microvilli), 
integrity of the internal elastic lamina (LEI), quality of 
smooth-muscle c lls (SMC) (i.e., normal distribution 
of chromatin), and integrity of the media (MI) (i.e., 
medial necrosis, elastin content of the media, and 
infiltration of the graft). The specimens were scored 
on a 0 to 3 scale for each item (EC, LEI, SMC, MI, 
Elastin): 0: bad quality, 1: poor quality, 2: moderate 
quality, 3: good quality. 
For scanning electron microscopy the other lon- 
gitudinally cut half of the graft was placed in Kar- 
novsky's fixative for 24 hours. After fixation was 
performed, the specimens were dehydrated in graded 
ethanols and critical point-dried. Subsequently they 
were mounted on stubs with conductive glue, sputter- 
coated with 20 nm gold-palladium, and viewed with 
an ISI SS40 scanning electron microscope (Akashi, 
Ltd., Tokyo, Japan) at 10 kV accelerating voltage. 
Statistical analysis. Data were analyzed with the 
unpaired, double-sided, Student's t test. Statistical 
significance was considered at p < 0.05. Results are 
presented as means + SEM. 
RESULTS 
Average observation time of the animals (n = 9) 
after implantation ofcryopreserved arterial grafts was 
88 + 6 days. The average time of storage of the 
cryopreserved arterial grafts (n = 18) before implan- 
tation varied from 51 to 91 days. Table I summarizes 
the patency ratcs of the cxperimental groups and 
number of samples obtained for further evaluation. 
Fig. 1 shows the results of in vitro function of excised 
grafts in each experimental group. The function of 
cryopreserved grafts immediately after thawing is 
displayed for comparison. Baseline responses of ftesh 
grafts to KC1, L-phenylephrine, and methacholine 
were 63.0 _+ 8.6 mN, 42.0 _+ 5.3 mN, and 70.4%_ 
8.9%, respectively. 
Fig. 2 shows thickness of the media of grafts of 
each group compared with that of a control group of 
arteries (medial thickness, 223.61_ 9.33 gm [n = 
10]). No significant differences were found among 
measurements of proximal, middle, and distal thirds 
of excised grafts of groups A, B, and C. 
Fig. 3 shows the results ofsemiquantitative assess- 
ment of morphometric parameters (EC, LEI, SMC, 
medial integrity, and elastin content). In thawed 
cryopreserved grafts before implantation, the media 
appeared intact. However, SEM evaluation of the 
luminal side invariably demonstrated shedding and 
deterioration of the endothelial layer (Fig. 3). 
Group A, arterial autografts. Group A au- 
tografts were all angiographically patent after 3 
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Fig. 3. Morphologic analysis. Bar graphs showing average sum (±SEM) of morphologic 
parameters per group. Samples were scored on 0 to 3 scale: 0: bad quality, 1: poor quality, 2: 
moderate quality, 3: good quality. EC, Endothelial cell quality; LEI, lamina elastica interna; SMC, 
smooth-muscle c lls; M/, medial integrity; Elartin, elastin content in media. A, Autografts; B, 
allografts; C, allografts + CsA 25 mg/kg/day. 
months, showing widely patent anastomoses. On 
excision the grafts showed resilient vessel walls with 
minimal scar tissue formation. Functional responses 
to KC1, Phe, and Met were 36.9 + 10.6 mN, 31.5 + 
14.4 mN, and 59.3% + 20.4%, respectively, indicating 
adequate function. Thickness of the media in these 
grafts was 232.32 + 3.24 btm. After 3 months of 
implantation improvement of morphologic param- 
eters was noted, with complete reendothelialization, 
recovery of the smooth-muscle layer, and restoration 
of medial integrity. The internal elastic lamina and the 
elastic fibers in the media were largely unchanged. 
Group B, arterial allografts. In the allograft 
group without immunosuppressive tr atment, group 
B, four out of six grafts remained patent. On excision 
the allografts howed severe fibrotic encapsulation. 
Functional responses were 0 for all three agents used. 
The thickness of the media of grafts in this group was 
101.22 + 4.49 Bm. Allografts without immunosup- 
pressive protection scored low on all morphologic 
parameters. Endothelial cell quality was relatively 
good, which can be explained by host reendothelial- 
izafion. The disappearance and deterioration of 
smooth-muscle c lls in this group was related to loss 
of medial integrity resulting from necrosis of the 
media. A further decrease in quality of elastin com- 
pared with the preimplantation configuration was also 
evident in this group. Subintimal, medial, and adven- 
titial infiltration was low or nonexistent, because at 
the time of excision of the grafts all cellular elements 
in the grafts had been eliminated because of the 
immunologic attack. 
Group C, arterial allografts under hnmuno- 
suppressive protection by CsA. In the group of 
allografts under CsA treatment the average serum 
CsA level was 359.9 + 115.5 ~tg/L, indicating ad- 
equate immunosuppressive protection in dogs. The 
grafts were all patent after 3 months of implantation. 
On excision a mild perigraft tissue reaction was 
observed in various degrees. Responses to KC1, Phe, 
and Met were 34 + 7.5 mN, 29.8 + 7.0 raN, and 
46.2% + 3.2%, respectively, indicating adequate 
function. Medial thickness was 229.36 + 4.55 gin. 
Allografts under immunosuppressive protection 
showed optimal morphologic results. Reendothelial- 
ization was complete. The smooth-muscle layer ap- 
peared of good quality, and the elastin fibers showed 
no evidence of further deterioration from the preim- 
plantation configuration. Occasionally subintimal, 
medial, and adventitial infiltration was seen at the time 
of excision of these grafts. 
In all grafts of group C, Barr bodies were found to 
be positively stained in the nuclei of smooth-muscle 
cells. Quinacrine-stained sections were consistently 
negative for chromosome fluorescence. Thus chro- 
mosomal stainings of specimens in this group dem- 
onstrate that the host smooth-muscle c lls residing in 
the grafts were of host origin and had repopulated the 
graft. 
DISCUSSION 
In this study dog cryopreserved arterial grafts 
were implanted as autografts and allografts with and 
without he use of the immunosuppressant CsA. After 
thawing of cryopreserved arterial grafts was per- 
formed, no functional responses were detected. After 
implantation as autografts (group A), the grafts 
showed full recovery of functional responses. After 
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allograft implantation without immunosuppressive 
treatment (group B), no in vitro function was detect- 
able on excision of the grafts. However, allografts 
under immunosuppressive treatment (group C) 
showed remarkable r covery of functional responses, 
comparable with those of group A. 
In all groups a confluent endothelial layer of 
relatively good quality was observed. Because anon- 
functional, destructed, endothelial monolayer was 
found before implantation was performed, this obser- 
vation indicates that he luminal surfaces of grafts in all 
experimental groups underwent reendothelializatlon 
with host endothelial cells. However, this process 
seemed more efficient and complete in autografts and 
in allografts under CsA. 
Semiquantitative assessment of medial thickness 
showed that the media of groups A and C were of 
normal thickness. The media of grafts in group B 
showed a significant thinning (p < 0.05) compared 
with the control group and grafts in groups A and C. 
Morphologic analysis revealed that grafts of groups A 
and C again were of superior quality. In group B 
involution of smooth-muscle c lls and loss of medial 
integrity were seen. These observations are in keeping 
with the functional and medial thiclmess assessments 
as described previously. The use of arterial allografts 
has been associated with rejection leading to aneurys- 
mal dilatation, 6 whereas aneurysm formation has 
been found to be related with loss of medial thick- 
ness) s Because allografts under CsA treatment 
showed a functional medial layer with a normal 
thickness, aneurysmal dilatation of the graft is not 
likely to occur. 
In allograft experiments male arterial grafts were 
transplanted in female recipients to distinguish be- 
tween smooth-muscle c lls in the grafts, being of 
donor or host origin. After excision was performed, 
the grafts were stained with male and female specific 
chromosome stains. In the allografts without immu- 
nosuppressive treatment no viable smooth-muscle 
cells were observed. In the allografts under CsA 
treatment viable smooth:muscle lls were found on 
morphologic and functional evaluation. In these 
grafts stainings were consistently negative for male 
Y chromosomal functions; however, Barr bodies 
could be identified in the nuclei of smooth-muscle 
cells in all of these grafts. These observations dem- 
onstrate that cryopreserved arterial allografts under 
immunosuppressive protection with CsA are repopu- 
lated with host smooth-muscle c lls. Thus cryopre- 
served arterial allografts and allografts under CsA 
heal by ingrowth of host endothelial nd smooth- 
muscle cells. 
Cryoprcservation has been suggested topreserve 
cellular viability and structural integrity of grafts and 
to possibly decrease the immunologic response to 
transplantation. 16 The speed of freezing and thawing 
and the composition of the cryoprotective solution 
applied before freezing are important factors influ- 
encing the ultimate result of  cryopreservation) 7'is 
The methods ofcryopreservation applied in this study 
led to loss of endothelial smooth-muscle c lls of the 
graft. Therefore it remains doubtful whether viable 
cells are really needed in preserved grafts, when the 
eventual cell population is of recipient origin. The 
phenomena outlined previously demonstrate hat a 
cryopreserved arterial graft can be used without any 
viable cells but with a matrix facilitating ingrowth of 
recipient vascular cells, provided that rejection is 
controlled. Cryoprcscrvation leaves this matrix intact, 
making it, apart from the lengthy storage possibilities, 
an ideal method for preservation ofarteries. 
Repopulation of arterial allografts by endothelial 
and smooth-muscle c lls of the host is a remarkable 
phenomenon bserved in this study. It can be antici- 
pated that when an implanted allograft under immu- 
nologic protection has been fully repopulated by 
recipient cells, the immunologic response of the host 
to the graft may be attenuated. This would eventually 
obviate the need for immunosupprcssive th rapy with 
all its possible side effects. Temporary use of immu- 
nosuppressive agents for the protection of cryopre- 
served arterial allografts makes clinical application 
more acceptable. Further esearch will focus On the 
possibilities of tapering immunosuppressive th rapy 
and on the use of longer arterial segments a  required 
in clinical practice. 19,2° 
In conclusion, this study has shown that cryo- 
preservation leads to complete loss of function of 
arterial grafts and severe damage of the endothelial 
layer. However, cryopreserved arterial autografts 
transplanted in dogs and allografts treated with a 
therapeutic dose of CsA showed restoration of func- 
tional and morphologic parameters during implanta- 
tion and remained patent. These phenomena re 
explained by a process of graft repopulation with 
recipient cells, which in the allografts may allow for 
gradual tapering of the immunosuppressive regimen. 
Temporary use of cyclosporine for transplantation f 
cryopreserved allogeneic arterial grafts could make 
clinical application a feasible prospect. 
The authors thank Ernst Wijsmuller, MD, of the Bio 
Implant Service/Eurotransplant foundation, and Claes 
Wassenaar, MD, of the Heart Valve Bank Rotterdam for 
providing the logistics for cryopreservation. Theauthors are 
grateful to Mrs. Agnes Vink of the department ofanthro- 
JOURNAL OF VASCULAR SURGERY 
882 Vischjager et al. November 1996 
pogenetics for performing the chromosome staining for this 
study. 
REFERENCES 
1. Londrey GL, Ramsey DE, Hodgson KM, et al. Intrapopliteal 
bypass for severe ischaemia: comparison of autogenous vein, 
composite, and prosthetic grafts. J Vasc Surg 1991;5:631-6. 
2. Veith FJ, Gupta SK,-Ascer E, et al. Six year prospective 
multicenter randomized comparison ofantologous saphenous 
vein and expanded polytetrafluoroethylene grafts in inftain- 
guinal arterial reconstruction. J Vasc Surg 1986;3:104-14. 
3. Gross RE, Hurwitt ES, Bill AH, Peirce EC II. Preliminary 
observations on the use of human arterial grafts in the 
treatment of certain cardiovascular defects. N Engl J Med 
1948;239:578-9. 
4. Gross RE, Bill AH, Peirce EC II. Methods for preservation a d 
transplantation f arterial grafts. Surg Gynaecol Obstet 1949; 
88:689-98. 
5. Meade JW, Linton RR, Darling RC, Menendez CV. Arterial 
homografts. Arch Surg 1966;93:392-9. 
6. Szilagyi DE, Rodriguuez FJ, Smith RF, Elliot JP. Late fate of 
arterial allografts. Arch Surg 1970;101:721-33. 
7. Merhi Y, Roy R, Douville Y, et al. Fresh venous femoral 
autografts and allografts as carotid substitutes inmatched ogs 
from the same litter. J Cardiovasc Surg 1990;31:147-55. 
8. Ochsner JL, Lawson JD, Eskind SJ, Mills NL, DeCamp PT. 
Homologous veins as an arterial substitute: long-term results. 
J Vasc Surg 1984;1:306-13. 
9. Harris RW, Schneider PA, Andros G, Oblath RW, Salles- 
Cunha S, Dulawa L. Allograft vein bypass: is it an acceptable 
alternative for infrapopliteal revascularization? J Vasc Surg 
1993;18:553-60. 
10. Vischjager M, Van Gulik TM, PfaffendorfM, et al. Morphol- 
ogy and function of dog arterial grafts preserved in UW- 
solution. Eur J Vasc Endovasc Surg 1995;10:431-9. 
11. Kadoba K, Armiger L, Sawatari K, Jonas RA. Influence of time 
from donor death to graft harvest on conduit function of 
cryopreserved aortic allografts in lambs. Circulation 1991;84: 
III100-III111. 
12. Tijssen E, Bos E, Konertz W, Van Suylen RJ, De By TMMH. 
Kryoconservierung humaner spenderherzklappen in der 
hertzklappenbank in Rotterdam. Z Herz-, Thorax-, und 
Gefasschirurgie 1992;6:49-55. 
13. Lange PL, Hopkins RA. Allograft valve banking: techniques 
and technology. In: Hopkins RA, editor. Cardiac reconstruc- 
tions with allograft valves. New York: Springer, 1989:35-63. 
14. Pfaffendorf M, Mathy MJ, Van Zwieten PA. Differential 
effects of various dihydropyridine calcium antagonists on the 
contraction of rat coronary artery stimulated with high potas- 
sium. Br J Pharmacol 1991;105:293-9. 
15. Schmitz-RLxen T, Megerman J, Colvin RB, Williams AM, 
Abbot WM. Immunosuppressive tr atment of aortic al- 
lografts. J Vasc Surg 1988;7:82-92. 
16. Miller VM, Bergman T, Gloviczki P, Brockbank KGM. Cryo- 
preserved venous allografts: effects ofimmunosuppression and
platelet therapy on patency and fimction. J Vasc Surg 1993; 
18:216-26. 
17. Brockbank EGM, Donovan TJ, Ruby ST, Carpenter JF, 
Hagen PO, Woodley MA. Functional analysis ofcryopreserved 
veins: preliminary report. J Vasc Surg 1990;11:94-102. 
18. Mtiller-Schweinitzer E, Ellis P. Sucrose promotes the func- 
tional activity of blood vessels after cryopreservation i  
DMSO-containing fetal calf serum. Naunyn-Schmedeberg's 
Arch Pharmacol 1992;345:594-7. 
19. Gournier JP, Adham M, Favre JP, et al. Cryopreserved arterial 
homografts: preliminary study. Ann Vasc Surg 1993;7:503- 
11. 
20. Dinis Da Gama A, Sarmento C, Vieira T, Do Carmo GX. The 
use of arterial allografts for vascular reconstruction in patients 
receiving immunosuppression for organ transplantation. 
J Vasc Surg 1994;20:271-80. 
Submitted Sep. 6, 1995; accepted Mar. 29, 1996. 
